TAK‐044: An Endothelin Receptor Antagonist
- 1 March 1996
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 14 (1) , 36-46
- https://doi.org/10.1111/j.1527-3466.1996.tb00312.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Nonselective ETA/ETB receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplastyLife Sciences, 1995
- Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injuryHepatology, 1995
- Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in ratsLife Sciences, 1994
- The current endothelin receptor classification: time for reconsideration?Trends in Pharmacological Sciences, 1994
- Cyclic Hexapeptide Endothelin Receptor Antagonists Highly Potent for Both Receptor Subtypes ETA and ETBBiochemical and Biophysical Research Communications, 1994
- Endothelium-derived contracting factors.Hypertension, 1992
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Pathophysiological role of endothelin in acute renal failureLife Sciences, 1990
- Positive Inotropic and Vasoconstrictive Effects of Endothelin-1 in in vivo and in vitro ExperimentsJournal of Cardiovascular Pharmacology, 1989